AgingResearch.News
Alzheimer's & Dementia

Sex- and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer's disease

By Francesca Vitali, Adam C. Raikes, Simona Merlini, Show 3 more authorsFei Yin
Figure 1. Overview of the sex‐ and APOE‐informed drug repurposing framework for AD.
Open the figure at full size
Figure 1. Overview of the sex‐ and APOE‐informed drug repurposing framework for AD.Overview of the sex‐ and APOE‐informed drug repurposing framework for AD.Vitali et al.
Cohort study of 369 peopleInterventions

Declared ties to: ADM Diagnostics

Paper

The paper

Francesca Vitali, Adam C. Raikes, Simona Merlini, Show 3 more authorsFei Yin

University of Arizona

Alzheimer's & Dementia, 22 Aug 2026

doi.org/10.1002/trc2.70303PubMed 42633094

More on Immune response